ELUVOGUE

Serial Number 87874399
606

Registration Progress

Application Filed
Apr 12, 2018
Under Examination
Sep 25, 2018
Approved for Publication
Jul 31, 2018
Published for Opposition
Jul 31, 2018
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ELUVOGUE
Previous Owner: AbbVie Biotechnology Ltd
Classes: 005

Trademark Image

ELUVOGUE

Basic Information

Serial Number
87874399
Filing Date
April 12, 2018
Published for Opposition
July 31, 2018
Abandonment Date
November 1, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 1, 2021
Classes
005

Rights Holder

AbbVie Biotechnology Ltd

03
Address
Clarendon House, 2 Church Street
Hamilton HM11
BM

Ownership History

AbbVie Biotechnology Ltd

Original Applicant
03
Hamilton BM

AbbVie Biotechnology Ltd

Owner at Publication
03
Hamilton BM

Legal Representation

Attorney
Cheryl A. Withycombe

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

31 events
Date Code Type Description Documents
Nov 1, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 1, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 19, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 8, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 19, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 16, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 16, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 17, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 13, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 13, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 13, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 24, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 20, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 20, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 5, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 5, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 25, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 31, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 31, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 11, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 26, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 20, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 16, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification

International Classes
005